Polydatin ameliorates Staphylococcus aureus-induced mastitis in mice via inhibiting TLR2-mediated activation of the p38 MAPK/NF-κB pathway

Acta Pharmacol Sin. 2017 Feb;38(2):211-222. doi: 10.1038/aps.2016.123. Epub 2016 Nov 28.

Abstract

Recent studies show that Polydatin (PD) extracted from the roots of Polygonum cuspidatum Sieb, a widely used traditional Chinese remedies, possesses anti-inflammatory activity in several experimental models. In this study, we investigated the anti-inflammatory effects of PD on Staphylococcus aureus-induced mastitis in mice and elucidated the potential mechanisms. In mice with S aureus-induced mastitis, administration of PD (15, 30, 45 mg/kg, ip) or dexamethasone (Dex, 5 mg/kg, ip) significantly suppressed the infiltration of inflammatory cells, ameliorated the mammary structural damage, and inhibited the activity of myeloperoxidase, a biomarker of neutrophils accumulation. Furthermore, PD treatment dose-dependently decreased the levels of TNF-α, IL-1β, IL-6 and IL-8 in the mammary gland tissues. PD treatment also dose-dependently decreased the expression of TLR2, MyD88, IRAK1, IRAK4 and TRAF6 as well as the phosphorylation of TAK1, MKK3/6, p38 MAPK, IκB-α and NF-κB in the mammary gland tissues. In mouse mammary epithelial cells (mMECs) infected by S aureus in vitro, pretreatment with PD dose-dependently suppressed the upregulated pro-inflammatory cytokines and signaling proteins, and the nuclear translocation of NF-κB p65 and AP-1. A TLR2-neutralizing antibody mimicked PD in its suppression on S aureus-induced upregulation of MyD88, p-p38 and p-p65 levels in mMECs. PD (50, 100 μg/mL) affected neither the growth of S aureus in vitro, nor the viability of mMECs. In conclusion, PD does not exhibit antibacterial activity against S aureus, its therapeutic effects in mouse S aureus-induced mastitis depend on its ability to down-regulate pro-inflammatory cytokine levels via inhibiting TLR2-mediated activation of the p38 MAPK/NF-κB signaling pathway.

MeSH terms

  • Animals
  • Anti-Inflammatory Agents / pharmacology
  • Cell Survival / drug effects
  • Cytokines / metabolism
  • Dexamethasone / pharmacology
  • Dose-Response Relationship, Drug
  • Down-Regulation / drug effects
  • Female
  • Glucosides / pharmacology*
  • Inflammation Mediators / metabolism
  • MAP Kinase Signaling System / drug effects*
  • Mastitis / drug therapy*
  • Mastitis / immunology
  • Mastitis / metabolism
  • Mastitis / microbiology
  • Mice
  • NF-kappa B / metabolism*
  • Neutrophil Infiltration / drug effects
  • Peroxidase / antagonists & inhibitors
  • Staphylococcus aureus / drug effects*
  • Staphylococcus aureus / immunology
  • Stilbenes / pharmacology*
  • Toll-Like Receptor 2 / antagonists & inhibitors*
  • Toll-Like Receptor 2 / immunology
  • p38 Mitogen-Activated Protein Kinases / metabolism*

Substances

  • Anti-Inflammatory Agents
  • Cytokines
  • Glucosides
  • Inflammation Mediators
  • NF-kappa B
  • Stilbenes
  • Tlr2 protein, mouse
  • Toll-Like Receptor 2
  • Dexamethasone
  • Peroxidase
  • p38 Mitogen-Activated Protein Kinases
  • polydatin